Literature DB >> 31144384

Silence of lncRNA HEIH suppressed liver cancer cell growth and metastasis through miR-199a-3p/mTOR axis.

Yongbiao Ma1, Gaoxue Li2, Jingxia Hu3, Xin Liu4, Jianling Liu5.   

Abstract

BACKGROUND/AIMS: High expression in hepatocellular carcinoma (HEIH) is an long noncoding RNA (lncRNA) which is highly expressed in hepatocellular carcinoma (HCC). Aberrant expression of HEIH is implicated in regulating HCC cells growth and metastasis. This study attempted to illustrate the effects of HEIH on HCC cell lines.
METHODS: The expression changes of HEIH in HCC tumor tissues and the paracancerous tissues derived from 20 patients with HCC were tested. Effects of HEIH on Huh7 and Hep3B cells viability, apoptosis, migration, and invasion were assessed by silencing HEIH in vitro. Furthermore, downstream effector and signaling of HEIH were studied.
RESULTS: As compared with the paracancerous tissues, the HEIH expression was highly expressed in tumor tissues. Silence of HEIH significantly reduced Huh7 and Hep3B cells viability, migration, and invasion, but induced apoptosis. It was coupled with the downregulated CyclinD1, Bcl-2, MMP-2, MMP-8, Vimentin, the upregulated p53, Bax, as well as the cleaved caspase-3. MicroRNA (miR)-199a-3p was identified as a downstream effector of HEIH, as its expression was upregulated by HEIH silence, and the functional effects of HEIH on Huh7 and Hep3B cells were all attenuated when miR-199a-3p expression was suppressed. Furthermore, HEIH silence suppressed the activation of mTOR signaling via upregulating miR-199a-3p.
CONCLUSION: HEIH silence might be a promising target for suppressing HCC cells growth and metastasis. Silence of HEIH exerted its antitumor properties possibly through upregulating miR-199a-3p, and thereby blockage of mTOR signaling.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  hepatocellular carcinoma; lncRNA HEIH; mTOR signaling; miR-199a-3p

Mesh:

Substances:

Year:  2019        PMID: 31144384     DOI: 10.1002/jcb.29041

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  13 in total

1.  LncRNA HEIH regulates cell proliferation and apoptosis through miR-4458/SOCS1 axis in triple-negative breast cancer.

Authors:  Peng Li; Bo Zhou; Yuetao Lv; Qian Qian
Journal:  Hum Cell       Date:  2019-08-27       Impact factor: 4.174

2.  LncRNA HEIH Confers Cell Sorafenib Resistance in Hepatocellular Carcinoma by Regulating miR-98-5p/PI3K/AKT Pathway.

Authors:  Qian Shen; Shenhua Jiang; Mingyun Wu; Lei Zhang; Xue Su; Ding Zhao
Journal:  Cancer Manag Res       Date:  2020-07-29       Impact factor: 3.989

3.  The effect of targeted regulation of LATS2 by LncRNA BCAR4 on proliferation, migration and apoptosis of HCC cells.

Authors:  Yuntao Huang; Xiaohui Rao; Yunfan Luo; Yu Deng; Chunqiang Zhong
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

4.  lncRNA HEIH, an indicator of high malignancy and poor prognosis, functions as an oncogene in breast cancer.

Authors:  Cheng Chen; Cheng Gu; Qian Ren; Fanghui Ding; Qing Pan; Yicong Niu; Dachang Ma; Li Wu
Journal:  Mol Med Rep       Date:  2020-07-23       Impact factor: 2.952

5.  Long noncoding RNA HEIH depletion depresses esophageal carcinoma cell progression by upregulating microRNA-185 and downregulating KLK5.

Authors:  Bing Wang; Xuezhi Hao; Xingkai Li; Yicheng Liang; Fang Li; Kun Yang; Hengqi Chen; Fang Lv; Yushun Gao
Journal:  Cell Death Dis       Date:  2020-11-22       Impact factor: 8.469

Review 6.  Circulating Long and Circular Noncoding RNA as Non-Invasive Diagnostic Tools of Hepatocellular Carcinoma.

Authors:  Caecilia H C Sukowati; Loraine Kay D Cabral; Claudio Tiribelli; Devis Pascut
Journal:  Biomedicines       Date:  2021-01-19

Review 7.  Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway.

Authors:  Mengnan Guo; Ning Li; Jianxia Zheng; Wei Wang; Yan Wu; Xu Han; Jiapei Guo; Weixi Chen; Zekun Bai; Wen Bai; Jinghua Wu
Journal:  Can J Gastroenterol Hepatol       Date:  2021-05-25

8.  Serum-derived three-circRNA signature as a diagnostic biomarker for hepatocellular carcinoma.

Authors:  Xiang-Hong Sun; Yu-Tong Wang; Guo-Fu Li; Nan Zhang; Ling Fan
Journal:  Cancer Cell Int       Date:  2020-06-10       Impact factor: 5.722

9.  Landscape of associations between long non-coding RNAs and infiltrating immune cells in liver hepatocellular carcinoma.

Authors:  Li Li; Xiaowei Song; Yanju Lv; Qiuying Jiang; Chengjuan Fan; Dayong Huang
Journal:  J Cell Mol Med       Date:  2020-09-10       Impact factor: 5.310

10.  New Therapeutic Options for Advanced Hepatocellular Carcinoma.

Authors:  Yu-Shui Ma; Ji-Bin Liu; Ting-Miao Wu; Da Fu
Journal:  Cancer Control       Date:  2020 Jul-Aug       Impact factor: 3.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.